Filtered By:
Specialty: Neurology
Procedure: Deep Brain Stimulation
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 1184 results found since Jan 2013.
Bridging the Gaps in Patient Education for DBS Surgery in Parkinson's Disease.
CONCLUSIONS: Our findings demonstrate that patients' expectations of DBS surgery in PD were at least partially met. However, there was a considerable percentage of patients who did not feel adequately prepared for the procedure. A structured, multidisciplinary team approach in educating PD patients throughout the different stages of DBS surgery may be helpful in optimizing patients' experience and satisfaction with surgery outcomes.
PMID: 28848685 [PubMed]
Source: Parkinsons Disease - August 31, 2017 Category: Neurology Tags: Parkinsons Dis Source Type: research
Comorbidities and the Outcome of Deep Brain Stimulation Surgery in Parkinson's Disease (P7.048)
CONCLUSION:Most PD patients with very significant co-morbidities were probably excluded from surgery, making our cohort less diverse in the comorbidity spectrum. Nonetheless, in this "vetted" cohort of PD patients, the number, type, and severity of comorbidities, had no significant influence on outcome of DBS surgery at 1 year.REFERENCES:1-Charlson M, Szatrowski TP,Peterson J,Gold J.Validation of a combined comorbidity index. J Clin Epidemiol. 1994 Nov;47(11):1245-51.2-Elixhauser A, Steiner C, Harris DR, Coffey RM.Comorbidity measures for use with administrative data. Med Care. 1998 Jan;36(1):8-27.Disclosure: Dr. Alsallom ...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Alsallom, F., Abboud, H., Genc, G., Oravivattanakul, S., Ahmed, A., Cooper, S., Gostkowski, M., Machado, A., Fernandez, H. Tags: Movement Disorders: Deep Brain Stimulation for Parkinson ' s Disease Source Type: research
Impact of Socioeconomic Status on Outcome of Deep Brain Stimulation Surgery for Parkinson's Disease (P7.058)
CONCLUSION:Our study shows that although PD patients with higher income households had somewhat better functional improvement at 1 year, this did not translate to better quality of life or overall clinical improvement. Household income was not a major influence in DBS outcomes in our cohort.Disclosure: Dr. Genc has nothing to disclose. Dr. Abboud has nothing to disclose. Dr. Oravivattanakul has nothing to disclose. Dr. Alsallom has nothing to disclose. Dr. Thompson has nothing to disclose. Dr. Cooper has nothing to disclose. Dr. Gostkowski has nothing to disclose. Dr. Machado has received personal compensation for activiti...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Genc, G., Abboud, H., Oravivattanakul, S., Alsallom, F., Thompson, N., Cooper, S., Gostkowski, M., Machado, A., Fernandez, H. Tags: Movement Disorders: Surgical Approaches to Parkinson ' s Disease Source Type: research
Estimating the Proportion of Essential Tremor and Parkinson's Disease Patients Referred for Deep Brain Stimulation: Five-Year Data from Columbia University Medical Center (2009-2014) (P4.146)
CONCLUSIONS: At our tertiary center, approximately 1-in-35 to 1-in-72 ET or PD patients were referred for DBS surgery. In this sample, the proportion with ET was higher than that of PD.Disclosure: Dr. Kestenbaum has nothing to disclose. Dr. Louis has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Kestenbaum, M., Louis, E. Tags: Neuroepidemiology: Movement Disorders, ALS, and Neuromuscular Source Type: research
Height and Weight Changes after Deep Brain Stimulation in patients with Parkinson Disease: Role of Clinical Subtypes (P6.053)
CONCLUSIONS: This study confirms BMI increase after DBS in PD patients and reports a novel finding of increased height after DBS in patients with the akinetic-rigid clinical subtype. This might be secondary to improved rigid posture following DBS. Study supported by: Cleveland Clinic.Disclosure: Dr. Reyes has nothing to disclose. Dr. Abboud has nothing to disclose. Dr. Genc has nothing to disclose. Dr. Machado has received personal compensation for activities with IntElect Medical/Boston Scientific, ATI, CardioNomics, and Monteris Medical as a consultant. Dr. Cooper has nothing to disclose. Dr. Gostkowski has nothing to di...
Source: Neurology - April 8, 2015 Category: Neurology Authors: Reyes, D., Abboud, H., Genc, G., Machado, A., Cooper, S., Gostkowski, M., Fernandez, H. Tags: Movement Disorders: Parkinson ' s Disease Source Type: research
Interventional Psychiatry and Neurotechnologies: Education and Ethics Training
Can J Neurol Sci. 2023 Jun;50(s1):s10-s16. doi: 10.1017/cjn.2023.27. Epub 2023 May 10.ABSTRACTThe last two decades have seen dramatic growth in the application of procedurally based interventions for treating refractory psychiatric conditions, leading to interest in developing the foundations for the subspecialty of "Interventional Psychiatry." However, there is cause for concern that the rate of expansion of clinical advances in this field may be outpacing the ability of postgraduate curricula to provide sufficient exposure to and teaching and supervision of these treatments. The paucity of adequately trained practitioner...
Source: The Canadian Journal of Neurological Sciences - May 9, 2023 Category: Neurology Authors: Peter Giacobbe Amer M Burhan Robyn Waxman Enoch Ng Source Type: research
Neuromodulation for Cognitive Disorders: In Search of Lazarus ?
Hooman AzmiNeurology India 2020 68(8):288-296
Alzheimer's disease (AD) and other forms of dementia can have a large impact on patients, their families, and for the society as a whole. Current medical treatments have not shown enough potential in treating or altering the course of the disease. Deep brain stimulation (DBS) has shown great neuromodulatory potential in Parkinson's disease, and there is a growing body of evidence for justifying its use in cognitive disorders. At the same time there is mounting interest at less invasive and alternative modes of neuromodulation for the treatment of AD. This...
Source: Neurology India - December 5, 2020 Category: Neurology Authors: Hooman Azmi Source Type: research
Cost‐utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trial
ConclusionIn this patient group, DBS is not cost‐effective at 1 year. Extrapolation, however, reveals an increasing likelihood of cost‐effectiveness up to 5 years and reducing cost‐effectiveness between 5 and 10 years. These models are sensitive to assumptions about future costs and quality‐adjusted life years gained. © 2016 International Parkinson and Movement Disorder Society
Source: Movement Disorders - January 1, 2016 Category: Neurology Authors: Emma McIntosh, Alastair Gray, Jane Daniels, Steven Gill, Natalie Ives, Crispin Jenkinson, Rosalind Mitchell, Hardev Pall, Smitaa Patel, Niall Quinn, Caroline Rick, Keith Wheatley, Adrian Williams, Tags: Research Article Source Type: research
Cost ‐utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trial
ConclusionIn this patient group, DBS is not cost‐effective at 1 year. Extrapolation, however, reveals an increasing likelihood of cost‐effectiveness up to 5 years and reducing cost‐effectiveness between 5 and 10 years. These models are sensitive to assumptions about future costs and quality‐adjusted life years gained. © 2016 International Parkinson and Movement Disorder Society
Source: Movement Disorders - February 4, 2016 Category: Neurology Authors: Emma McIntosh, Alastair Gray, Jane Daniels, Steven Gill, Natalie Ives, Crispin Jenkinson, Rosalind Mitchell, Hardev Pall, Smitaa Patel, Niall Quinn, Caroline Rick, Keith Wheatley, Adrian Williams, Tags: Research Article Source Type: research
Medical management after subthalamic stimulation in Parkinson’s disease: a phenotype perspective
In this study, we review the literature data on acute medical management after STN DBS in PD and propose a clinical algorithm on medical management focused on the patient ’ s phenotypic profile at the perioperative period. Overall, across the trials, the levodopa equivalent daily dose is reduced by 30 to 50% one year after surgery. In patients taking high doses of dopaminergic drugs or with high risk of impulse control disorders, an initial reduction in dopamine agonists after STN DBS is recommended to avoid the hyperdopaminergic syndrome, particularly hypomania. On the other hand, a rapid reduction of dopaminergic agoni...
Source: Arquivos de Neuro-Psiquiatria - May 1, 2020 Category: Neurology Source Type: research
Evaluating reflexive saccades and UDPRS as markers of Deep Brain Stimulation and Best Medical Treatment improvements in Parkinson's disease patients: a prospective controlled study.
CONCLUSION: RS parameters correlated with UPDRS III outcomes during the postoperative period in DBS-STN patients. Therefore, saccadic evaluation may be a good biomarker of the patient's response to surgical and/or pharmacological treatment.
PMID: 31621890 [PubMed - as supplied by publisher]
Source: Neurologia i Neurochirurgia Polska - October 16, 2019 Category: Neurology Authors: Szlufik S, Przybyszewski A, Dutkiewicz J, Mandat T, Habela P, Koziorowski D Tags: Neurol Neurochir Pol Source Type: research
